Cancer prevention in the esophagus could be just a pill away, doctor says: ‘Tremendous benefit’
February 27, 2024
Esophageal cancer has a low five-year survival rate and lacks routine screening methods. The EsoGuard test detects precancerous conditions related to gastroesophageal reflux disease (GERD), a known risk factor. The test involves swallowing a capsule that collects cells from the esophagus, avoiding the need for invasive endoscopy. Lucid Diagnostics has partnered with fire departments to screen high-risk firefighters. Early detection can enable timely interventions, potentially reducing cancer deaths. The test is highly sensitive and minimally invasive.
See original news story: